Sinopharm Group Co., Ltd.

  • Market Cap: N/A
  • Industry: Retailing
  • ISIN: CNE100000FN7
HKD
20.36
0.22 (1.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Sino Biopharmaceutical Ltd.
WuXi AppTec Co., Ltd.
China Medical System Holdings Ltd.
Sinopharm Group Co., Ltd.
China Resources Pharmaceutical Group Ltd.
Hygeia Healthcare Holdings Co., Ltd.
Hansoh Pharmaceutical Group Co., Ltd.
Innovent Biologics, Inc.
Akeso, Inc.
HUTCHMED (China) Ltd.
BeiGene Ltd.
Why is Sinopharm Group Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
  • High Debt Company with a Debt to Equity ratio (avg) at times
2
High Debt company with Weak Long Term Fundamental Strength
3
Negative results in Dec 24
  • OPERATING CASH FLOW(Y) Lowest at HKD 10,717.28 MM
  • ROCE(HY) Lowest at 9.21%
  • RAW MATERIAL COST(Y) Grown by 21.98% (YoY)
4
Underperformed the market in the last 1 year
  • Even though the market (Hang Seng Hong Kong) has generated returns of 26.67% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -3.96% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sinopharm Group Co., Ltd. for you?

Low Risk, High Return

Absolute
Risk Adjusted
Volatility
Sinopharm Group Co., Ltd.
-5.52%
21.04
22.89%
Hang Seng Hong Kong
27.36%
1.03
25.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
5.58%
EBIT Growth (5y)
-0.84%
EBIT to Interest (avg)
5.74
Debt to EBITDA (avg)
1.71
Net Debt to Equity (avg)
0.57
Sales to Capital Employed (avg)
3.03
Tax Ratio
27.95%
Dividend Payout Ratio
30.17%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
18.45%
ROE (avg)
19.69%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
2
Industry P/E
Price to Book Value
0.30
EV to EBIT
3.87
EV to EBITDA
3.04
EV to Capital Employed
0.55
EV to Sales
0.11
PEG Ratio
NA
Dividend Yield
8.68%
ROCE (Latest)
14.25%
ROE (Latest)
14.39%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Sinopharm Group Co., Ltd.
Dividend Payout Ratio
Highest at 63.54%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Depreciation
Highest at HKD 2,612.77 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Here's what is not working for Sinopharm Group Co., Ltd.
Operating Cash Flow
Lowest at HKD 10,717.28 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Net Sales
Lowest at HKD 314,358.37 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (HKD MM)

Pre-Tax Profit
Lowest at HKD 7,512.23 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

EPS
Lowest at HKD 1.16
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (HKD)

Dividend per share
Lowest at HKD 2.96
in the last five years
MOJO Watch
Company is distributing lower dividend than previous years

DPS (HKD)

Raw Material Cost
Grown by 21.98% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales